Mortality and Generalizability of the National Lung Screening Trial
This cohort study evaluates all-cause mortality of National Lung Screening Trial participants compared with those of similar age and tobacco use in a national Veterans Health Administration cohort.
Authors
- Katherine J. Hoggatt (ORCID: https://orcid.org/0000-0002-9431-5438)
- Louise C. Walter (ORCID: https://orcid.org/0000-0002-9642-6238)
- Emily Lum
- Amy L. Byers
- Beth Cohen (ORCID: https://orcid.org/0009-0008-4648-2152)
- Salomeh Keyhani (ORCID: https://orcid.org/0000-0001-9124-9618)
- Frank J. Graham (ORCID: https://orcid.org/0000-0003-4581-3892)
- Marzieh Vali
- Alison S. Rustagi
Institutions
- San Francisco VA Medical Center (US)
- University of California, San Francisco (US)
- San Francisco VA Health Care System (US)
- Northern California Institute for Research and Education (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-04-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.8622
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00